Home › Funds › Helikon Investments Ltd › ABVX
Helikon Investments Ltd position in ABVX
ABIVAX SA · Health Care
Helikon Investments Ltd reported holding 4,222,896 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$418.2M, representing 11.88% of its reported portfolio and ranking #3 among its reported holdings. Helikon Investments Ltd has disclosed ABVX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Helikon Investments Ltd's ABVX position evolved
Helikon Investments Ltd first disclosed a stake in ABVX in Q1 2026 at 1,013,324 shares (US$112.8M). The position peaked in Q3 2026 at 4,222,896 shares, worth US$418.2M. Across 3 filings, Helikon Investments Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,222,896 shares valued at US$418.2M — an increase of 1,435,765 shares quarter over quarter.. Notable position changes include a 175% increase in Q2 2026 (shares fell 26% over the following quarter), a 52% increase in Q3 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.01M | $112.83M | New |
| Q2 2026 | 2.79M | $371.41M | Add |
| Q3 2026 | 4.22M | $418.15M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 70 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Darwin Global Management, Ltd. (US$348.2M), Vestal Point Capital, LP (US$313.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- TCG Crossover Management, LLC 6.01M sh · $800.60M · Q2 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- Caligan Partners LP 1.56M sh · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.65M sh · $163.56M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Logos Global Management LP 1.02M sh · $136.46M · Q2 2026
- Octagon Capital Advisors LP 993.00K sh · $132.33M · Q2 2026
- Eversept Partners, LP 913.88K sh · $121.78M · Q2 2026
- Cormorant Asset Management, LP 675.00K sh · $89.95M · Q2 2026
- Boxer Capital Management, LLC 605.00K sh · $80.62M · Q2 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 762.82K sh · $75.53M · Q3 2026
More on Helikon Investments Ltd
FAQ
How long has Helikon Investments Ltd held ABVX?
Helikon Investments Ltd has disclosed ABVX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Helikon Investments Ltd's current position in ABVX?
As of Q3 2026, Helikon Investments Ltd holds 4.22M shares of ABVX (ABIVAX SA), valued at $418.15M, representing 11.88% of its reported portfolio and ranking #3.
Has Helikon Investments Ltd been buying or selling ABVX?
In the latest 13F filing (Q3 2026), Helikon Investments Ltd increased its position in ABVX. The position peaked in Q3 2026 at 4.22M shares.
Which other funds hold ABVX?
Other major institutional holders of ABVX include TCG Crossover Management, LLC, Darwin Global Management, Ltd., Vestal Point Capital, LP, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.